Target ALS Team
We have built a team that brings together a unique mix of clinical, scientific, business, and philanthropic expertise.
Who are the people behind Target ALS?
At Target ALS, we’re defined by impatient optimism, driven by the urgency of a disease that leaves little time to wait. We believe breakthroughs are possible and we pursue them with purpose and persistence.
Our work embodies deliberate disruption, challenging the status quo through open science, bold partnerships, and global access to shared resources that remove barriers and accelerate discovery.
Above all, we believe in radical collaboration; uniting scientists, clinicians, industry leaders, and advocates in a transparent, inclusive ecosystem that turns collective knowledge into real progress for people living with ALS.
zlatan
Test
tggdfd
ialda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
aalda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
talda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
rlda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
The Target ALS Board of Directors
The Target ALS Board of Directors sets overall policy and guides the Foundation’s executive leadership team. To ensure we craft truly groundbreaking strategies to foster collaboration and accelerate drug discovery and development, we have recruited a renowned, passionate group of pioneering academic leaders, pharmaceutical and biotech executives, people with ALS and their family members, visionary philanthropists, and seasoned leaders from technology, law, venture capital, and other critical industries.
zlatan
Test
tggdfd
ialda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
aalda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
talda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
rlda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
The Target ALS Independent Review Committee
The Target ALS Independent Review Committee (IRC) evaluates and makes all research funding decisions. The IRC is comprised of experts across scientific disciplines from both industry and academia, reflecting the evolving nature of ALS research. To avoid any possible conflicts of interest, no member of the IRC can apply for or receive Target ALS funding for their own research. The committee is chaired by Robert Miller, Ph.D., George Washington University.
zlatan
Test
tggdfd
ialda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
aalda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
talda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
rlda Nehme, Ph.D. test
Ralda Nehme is an institute scientist and principal investigator in the Stanley Center for Psychiatric Research at the B…
Conflict of Interest Committee
To avoid Conflicts of Interest (COI), all board and committee members, as well as staff, abide by a comprehensive COI policy and are neither allowed to apply for, nor receive funding from, Target ALS.
Chris Henderson, Ph.D.
Former Chief Scientific Officer, Alltrna
Robert Miller, Ph.D.
Chair, Target ALS IRC Vice Dean for Research & Academic Affairs, George Washington University
Legacy Leadership
We honor the individuals whose leadership and service helped shape Target ALS. Their contributions continue to influence our work to accelerate ALS research and drive progress for the ALS community.
This recognition includes former leaders who served Target ALS with distinction, including those who have completed their service and those whose legacy continues to inspire our mission.
Eric Dane † (1972-2026)
Board Member
Story Landis, Ph.D.
Board Member
Mike Poole, M.D. † (1956-2024)
Board Member
Zach Hall, Ph.D.
Board Member & Scientific Advisor